News from ChromaDex A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( OTC-BB:CDXC)

Mar 19, 2015, 06:35 ET

ChromaDex® Reports 2014 Ingredient Sales Grew 182%

 ChromaDex Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the...

Mar 05, 2015, 06:30 ET

ChromaDex to Present at the Northland Capital Markets 2015 Growth Conference on March 18, 2015

 ChromaDex Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to...

Mar 03, 2015, 06:30 ET

ChromaDex® Appoints Former Nestle Executive, Steve Allen, as Chairman

ChromaDex® Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to...

Feb 18, 2015, 06:30 ET

ChromaDex® to Present at the 27th Annual ROTH Conference on March 10, 2015

ChromaDex® Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to...

Feb 11, 2015, 06:30 ET

ChromaDex's NIAGEN™ Nicotinamide Riboside Meets Primary Endpoint in First Human Clinical Study

 ChromaDex Corp. (OTCQX: CDXC) announced today that the initial results of the first human clinical study for the company's NIAGEN®...

Feb 05, 2015, 06:25 ET

Sports Nutrition Supplier BPI Sports Adopts ChromaDex® Quality Verification Seal Program

 ChromaDex Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the...

Jan 06, 2015, 06:30 ET

ChromaDex® CEO to Present at The Sidoti & Company, LLC Emerging Growth Institutional Investor Forum on January 12th

 ChromaDex® Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions...

Dec 10, 2014, 06:30 ET

NIH Publishes Results of Preclinical Collaboration with ChromaDex Showing Potential Benefit of Nicotinamide Riboside

ChromaDex Corp.  (OTCQX: CDXC), announced today that the results of a mouse study performed in collaboration with ChromaDex by the National...

Dec 04, 2014, 06:30 ET

ChromaDex® CEO to Present at The Benchmark Company, LLC's Micro Cap Discovery One-on-One Conference on Dec. 11

ChromaDex® Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to...

Dec 03, 2014, 06:30 ET

ChromaDex® Receives $750,000 Cash from Previous Sale of its BluScience™ Line

 ChromaDex® Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

Dec 02, 2014, 08:00 ET

ChromaDex Licenses Exclusive Worldwide Patent Rights from the University of Mississippi for Microalgae Technology Targeting Immune Support

ChromaDex Corp. (OTCQX: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the...

Nov 24, 2014, 08:25 ET

ChromaDex Announces Two Patent Issuances for Novel Ingredient, Pterostilbene

 The U.S. Patent and Trademark Office has granted patent #8,809,400 B2 (referred to as the '400 patent) and #8,841,350 B2 (referred to as the...

Nov 17, 2014, 08:25 ET

University of Birmingham Receives Grant from Wellcome Trust to Support Human Research on ChromaDex's NIAGEN® Nicotinamide Riboside

 ChromaDex Corp.  (OTCQX: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

Nov 12, 2014, 08:25 ET

Animal Study Confirms Results of ChromaDex Human Clinical Study on Weight Loss with Pterostilbene

A recent study led by Saioa Gomez-Zorita published in the Journal of Agricultural and Food Chemistry has demonstrated the weight loss effects of...

Nov 07, 2014, 17:00 ET

ChromaDex to Begin Trading on OTCQX Marketplace on November 10

ChromaDex®Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions to...

Nov 06, 2014, 06:40 ET

ChromaDex® Reports Ingredient Sales Grew 160% in the Third Quarter

 ChromaDex® Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary, ingredients and science-based solutions...

Oct 06, 2014, 08:25 ET

New Edition of the Hayes' Principles and Methods of Toxicology Provides Critical New Chapter on Food Safety and Foodborne Toxicants

 ChromaDex Corp.  (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...

Oct 01, 2014, 08:25 ET

Life Extension Introduces a New Anti-Aging Supplement, NAD+ Cell Regenerator™, Featuring NIAGEN™

 ChromaDex Corp.  (OTCQB: CDXC), Life Extension announced today the launch of NAD+ Cell Regenerator™, an innovative nutritional...

Sep 30, 2014, 06:30 ET

ChromaDex Secures $5.0 Million in Growth Capital Financing from Hercules

 ChromaDex Corp. (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions to the...

Sep 22, 2014, 08:25 ET

University of California Irvine Completes Pterostilbene Study For Prevention of Skin Damage from UV Exposure

 ChromaDex Corp.  (OTCQB: CDXC), an innovative natural products company that provides proprietary ingredients and science-based solutions...